Higher Postinduction Infliximab Concentrations Are Associated With Improved Clinical Outcomes in Fistulizing Crohn’s Disease

Citation:

Papamichael K, Vande Casteele N, Jeyarajah J, et al. Am J Gastroenterol. 2021 May 1;116(5):1007-1014. PMID: 33929379; PMCID: PMC8095681.